Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence

Bibliographic Details
Main Author: Leonardo Furlan
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:The Lancet Regional Health. Americas
Online Access:http://www.sciencedirect.com/science/article/pii/S2667193X22001314
_version_ 1811219244757549056
author Leonardo Furlan
author_facet Leonardo Furlan
author_sort Leonardo Furlan
collection DOAJ
first_indexed 2024-04-12T07:22:57Z
format Article
id doaj.art-a18886573ab3492998049bb7a109450f
institution Directory Open Access Journal
issn 2667-193X
language English
last_indexed 2024-04-12T07:22:57Z
publishDate 2022-08-01
publisher Elsevier
record_format Article
series The Lancet Regional Health. Americas
spelling doaj.art-a18886573ab3492998049bb7a109450f2022-12-22T03:42:16ZengElsevierThe Lancet Regional Health. Americas2667-193X2022-08-0112100314Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absenceLeonardo Furlan0School of Medicine, University of São Paulo, 455 – Cerqueira César, CEP: 01246903, São Paulo, SP, Brazilhttp://www.sciencedirect.com/science/article/pii/S2667193X22001314
spellingShingle Leonardo Furlan
Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence
The Lancet Regional Health. Americas
title Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence
title_full Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence
title_fullStr Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence
title_full_unstemmed Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence
title_short Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence
title_sort hydroxychloroquine for early treatment of covid 19 absence of evidence is different from evidence of absence
url http://www.sciencedirect.com/science/article/pii/S2667193X22001314
work_keys_str_mv AT leonardofurlan hydroxychloroquineforearlytreatmentofcovid19absenceofevidenceisdifferentfromevidenceofabsence